摘要
目的探讨新产程对降低产时剖宫产率及母儿结局的临床影响。方法选取该院2014年2月—2016年2月收治的1 000名产妇作为研究对象,根据产程管理方案分为两组,各500名。分为原产程组(对照组),新产程组(观察组),比较两组对降低剖宫产率及母儿结局的影响。结果观察组中转剖宫产率(2.80%)、头盆不称剖宫产率(1.80%)、胎儿窘迫剖宫产率(1.00%)显著低于对照组8.00%、4.00%、3.40%,差异有统计学意义(χ~2=13.233,P1=0.000;χ~2=4.297,P2=0.038;χ~2=6.693,P3=0.000)。观察组产妇产后尿潴留率、产后出血率、新生儿窒息率分别为(2.40%)、(1.40%)、(0.40%),对照组的为(2.60%)、(1.60%)、(0.60%),两组差异无统计学意义(χ~2=0.041,P1=0.839;χ~2=0.068,P2=0.795;χ~2=0.201,P3=0.654)。观察组活跃期时间(60.74±2.11)min显著少于对照组(170.97±10.86)min,差异有统计学意义(t=222.797,P=0.000)。结论实施新产程使阴道试产时中转剖宫产率明显降低,但并不会增加母儿的不良影响,值得在临床进一步探讨和推广。
Objective To study the clinical effect of new production process on reducing the cesarean section rate at birth and maternal and infant outcomes. Methods 1000 cases of delivery women admitted and treated in our hospital from February 2014 to February 2016 were selected and divided into two groups with 500 cases in each according to the production process management plan, and the effect on reducing the cesarean section rate at birth and maternal and infant outcomes was compared between the two groups. Results The transit cesarean section rate, eephalopelvie disproportion cesarean section rate and fetal distress cesarean section rate in the observation group were obviously lower than those in the control group （2.80%, 1.80%, 1.00% vs 8.00%, 4.00%, 3.40%）, and the differences were statistically sig- nificant （χ^2=13.233, PI=0.000; χ^2=4.297, P2=0.038;χ^2=6.693, P3=0.000）, and the postpartum urinary retention rate, postpartum hemorrhage rate and neonatal asphyxia rate in the observation group and in the control group were respectively （2.40%）, （1.40%）, （0.40%） and （2.60%）, （1.60%）, （0.60%）, and the differences were not obvious （χ^2=0.041, PI= 0.839; χ^2=0.068, χ^2=0.795; χ^2=0.201, P3=0.654）, and the active period time in the observation group was obviously lower than that in the control group [（60.74±2.11）min vs （170.97± 10.86）mini, and the difference was statistically significant （t=222.797,P=0.000）. Conclusion The implementation of new production process can obviously reduce the cesarean section rate during vaginal trial delivery, without increasing the adverse effect of mothers and infants, which is worth further study and promotion in clinic.
作者
李娟
LI Juan(Tongnan District Maternal and Infant Heahheare Family Planning Service Center,Chongqing,402660 China)
出处
《系统医学》
2018年第21期111-113,共3页
Systems Medicine
关键词
新产程
剖宫产
妊娠结局
New production process
Cesarean section
Gestational outcome
